Topics

Aytu BioScience to acquire Innovus Pharmaceuticals

05:02 EDT 13 Sep 2019 | Pharmaceutical Business Review

This initial consideration to Innovus common shareholders is estimated to consist of approximately 4.2 million shares of Aytu stock. Additional consideration for up to $16 million in milestone

The post Aytu BioScience to acquire Innovus Pharmaceuticals appeared first on Pharmaceutical Business review.

Original Article: Aytu BioScience to acquire Innovus Pharmaceuticals

NEXT ARTICLE

More From BioPortfolio on "Aytu BioScience to acquire Innovus Pharmaceuticals"

Quick Search